**Core Concept**
The catecholamine biosynthesis pathway involves the conversion of the amino acid tyrosine into the neurotransmitters dopamine, norepinephrine, and epinephrine. This process is regulated by a series of enzyme-catalyzed reactions, with a key rate-limiting step controlled by a specific enzyme.

**Why the Correct Answer is Right**
The rate-limiting enzyme in catecholamine biosynthesis is tyrosine hydroxylase (TH). This enzyme catalyzes the hydroxylation of tyrosine to form L-DOPA, the first step in the catecholamine biosynthesis pathway. Tyrosine hydroxylase is subject to feedback inhibition by high levels of catecholamines, which helps regulate the production of these neurotransmitters. The activity of tyrosine hydroxylase is also influenced by the availability of its cofactor, tetrahydrobiopterin (BH4), and by various post-translational modifications.

**Why Each Wrong Option is Incorrect**
* **Option A:** Not specified. Although several enzymes are involved in catecholamine biosynthesis, tyrosine hydroxylase is the rate-limiting enzyme.
* **Option B:** Not specified. While other enzymes, such as DOPA decarboxylase, are crucial for catecholamine biosynthesis, they are not the rate-limiting enzyme.
* **Option C:** Not specified. This option is incomplete, but even if a specific enzyme were listed, it would not be the rate-limiting enzyme in catecholamine biosynthesis.

**Clinical Pearl / High-Yield Fact**
The catecholamine biosynthesis pathway is a key target for various medications, including monoamine oxidase inhibitors (MAOIs) and dopamine agonists. Understanding the regulation of this pathway is essential for the effective treatment of conditions such as Parkinson's disease and hypertension.

**Correct Answer:** C. Tyrosine hydroxylase.